Fact CheckerSign in

NCT05667935Not yet recruiting

Cognitive Impairment Cohort Study of the Elderly Population in SheMountain

Shanghai Cognitive Impairment Study of the Elderly Population: SheMountain Cohort

Source: ClinicalTrials.gov · Last updated 29 Dec 2022 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study is a prospective observational study, which involves a cohort of 2000 all-sex and all-ethnic people aged 60 years and above with permanent residence in Tianma area, SheMountain Town, Songjiang District (suburban area), Shanghai. Demographic information, neuropsychiatric scale, peripheral blood, APOE genotype, brain MRI, speech information, AV45-PET, FDG-PET, Tau-PET, GLP-1R PET, and cholinergic receptor probe (ASEM) PET were collected and analyzed. Follow-up visits were performed twice a year for 4 visits, and neuropsychiatric scales and biological samples were collected at each follow-up visit to construct a diagnostic model for patients with mild cognitive impairment, or Alzheimer's disease, as well as a predictive model for the progression of cognitive impairment.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
2000 (estimated)
First submitted
13 Dec 2022
Start date
26 Dec 2022
Primary completion date
31 Dec 2030
Lead sponsor
Ruijin Hospital
NCT number
NCT05667935

What you commit to

  • Study type: Observational
  • Planned participants: 2000
  • From 26 Dec 2022 to the primary completion date, 31 Dec 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Suffering from severe mental illness, tumor cachexia, severe liver and kidney dysfunction and other serious physical diseases and unable to cooperate
  • Uncorrectable visual or auditory impairment that hampers the completion of related examination.

Who the study is looking for

  • All genders and all ethnic groups aged 60 and above with permanent residence in Tianma area, SheMountain Town, Songjiang District (suburbs), Shanghai.
  • Agree to collect neuropsychiatric scales, biological samples, imaging and other examination information.
  • Agree to participate in this study and sign the informed consent form. And promise to abide by the research procedures, and cooperate with the implementation of the whole process of research

Age in the registry: 60 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Coordinator of this site? Confirm its status
ShanghaiChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.